“…CPS activated the mitogen–activated protein kinase (MAPK) and nuclear factor‐κB (NF‐κB) signaling pathways through several pattern recognition receptors (PRRs) such as Toll‐like receptor (TLR)‐2, TLR‐4, and Detin‐1, upregulated the expression of proinflammatory mediators tumor necrosis factor‐α (TNF‐α), IL‐1β, and IL‐12, and promoted respiratory burst activity and nitric oxide (NO) production, leading to the conversion of the macrophage phenotype from M2 to M1 and enhancing phagocytosis in mouse macrophage cell lines (Chen, Yuan, Wang, Song, & Zhang, ; Lee et al, ; Zhu et al, ). CPS enhanced spleen lymphocyte proliferation and activity in immunosuppressed or tumor‐bearing mice (Zhang, Yang, Chen, Hou, & Han, , Wang, Meng, et al, ).…”